CollPlant Biotechnologies Ltd Restricted Cash and Cash Equivalents
CollPlant Biotechnologies Ltd (CLGN) had Restricted Cash and Cash Equivalents of $22.37 million as of 2023-06-30, per its 6-K filed 2023-08-24.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-08-24
- 2023-06-30: Restricted Cash and Cash Equivalents $22.37M.
- 2022-12-31: Restricted Cash and Cash Equivalents $29.86M.
- 2022-06-30: Restricted Cash and Cash Equivalents $36.50M.
- 2021-12-31: Restricted Cash and Cash Equivalents $13.37M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2023-06-30 | $22.37M 6-K · filed 2023-08-24 |
| 2022-12-31 | $29.86M 20-F · filed 2023-03-29 |
| 2022-06-30 | $36.50M 6-K · filed 2023-08-24 |
| 2021-12-31 | $13.37M 20-F · filed 2023-03-29 |
| 2020-12-31 | $3.53M 20-F · filed 2023-03-29 |
| 2019-12-31 | $3.97M 20-F · filed 2022-03-24 |
| 2018-12-31 | $5.66M 20-F · filed 2020-04-01 |
| 2017-12-31 | $5.28M 20-F · filed 2020-04-01 |
| 2016-12-31 | $1.13M 20-F · filed 2020-04-01 |